CELEX: 62017TB0783
Language: en
Date: 2018-07-11 00:00:00
Title: Case T-783/17 R: Order of the President of the General Court of 11 July 2018 — GE Healthcare v Commission (Application for interim measures — Medicinal products for human use — Directive 2001/83/EC — Suspension of the marketing authorisation for contrast agents containing gadolinium for human use — Application for suspension of operation of a measure — Lack of urgency)

17.9.2018   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 328/50
            
         
      Order of the President of the General Court of 11 July 2018 — GE Healthcare v Commission
      (Case T-783/17 R)
      ((Application for interim measures - Medicinal products for human use - Directive 2001/83/EC - Suspension of the marketing authorisation for contrast agents containing gadolinium for human use - Application for suspension of operation of a measure - Lack of urgency))
      (2018/C 328/68)
      Language of the case: English
      
         Parties
      
      
         Applicant: GE Healthcare A/S (Oslo, Norway) (represented by: D. Scannell, Barrister, G. Castle and S. Oryszczuk, Solicitors)
      
         Defendant: European Commission (represented by: K. Mifsud-Bonnici and A. Sipos, acting as Agents)
      
         Re:
      
      Application pursuant to Articles 278 and 279 TFEU for the suspension of operation of Commission Implementing Decision C(2017) 7941 final of 23 November 2017, concerning, in the framework of Article 31 of Directive 2001/83/EC of the Parliament and of the Council, the marketing authorisations for gadolinimum-containing contrast agents for human use which contain one or more of the active substances ‘gadobenic acid, gadobutrol, gadodiamide, gadopentetic acid, gadoteric acid, gadoteridol, gadoversetamide and gadoxetic acid’.
      
         Operative part of the order
      
      
                  1.
               
               
                  The application for interim measures is dismissed.
               
            
                  2.
               
               
                  The costs are reserved.